LEANBIO SL - ES 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2021 0 11.102.823 1.393.893 1
2017 0 5.844.509 811.250 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
BIONANONET FORSCHUNGSGESELLSCHAFT MBH2
NANOMOL TECHNOLOGIES SL2
BIOKERALTY RESEARCH INSTITUTE AIE1
CENTRE DE RECHERCHE PUBLIC GABRIEL LIPPMAN1
CENYA IMAGING BV1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSORCIO CENTRO DE INVESTIGACION BIOMEDICA EN RED MP1
COVANCE LABORATORIES1
DRUG DEVELOPMENT AND REGULATION SL1
GRACE BIO SL1
INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH1
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH1
MYBIOTECH1
RESEARCH CENTER FOR NON DESTRUCTIVE TESTING1
RESEARCH CENTER PHARMACEUTICAL ENGINEERING1
TECHNION ISRAEL INSTITUTE OF TECHNOLOGY1
TOPAS THERAPEUTICS1
UNIVERSITY OF AARHUS1

Constancy:

Total number of partners: 20
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 20
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2021-03-01Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products Phoenixparticipant11.102.82312
2017-01-01Smart multifunctional GLA-nanoformulation for Fabry disease Smart-4-Fabryparticipant5.844.50910